Minerva 50mg Tablet
Prescription Required

Product introduction
Minerva 50mg Tablet should be taken just before a meal or along with the first mouthful of food. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your blood sugar levels. The dose may be increased gradually. Do not stop taking it without consulting your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness.
This medicine is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Monitor your blood sugar levels regularly while taking this medicine.
The most common side effects of this medicine include skin rash, flatulence (gas), stomach pain, and diarrhea. Please consult your doctor if these bother you or do not go away.
This medicine by itself does not cause hypoglycemia (low blood sugar levels). However, when used in combination with other diabetes medicines (especially insulin or sulphonylureas), it can lead to hypoglycemia (low blood sugar levels). Such episodes of hypoglycemia should be treated by taking plain glucose. Table sugar or common sugar will not help correct low blood sugar levels if you are taking this medicine.
Before taking it, let your doctor know if you have any kidney or liver problems. Do not take this medicine if you have ulceration or inflammation in the bowel (eg. ulcerative colitis or Crohn’s disease). Pregnant or breastfeeding women should also consult their doctor before taking it. Please tell your doctor about all the other medicines you are taking to make sure you are safe. Avoid excessive alcohol intake while taking this medicine as it may increase the risk of hypoglycemia (low blood sugar levels).
Uses of Minerva Tablet
Benefits of Minerva Tablet
In Type 2 diabetes mellitus
Side effects of Minerva Tablet
Common side effects of Minerva
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Minerva Tablet
How Minerva Tablet works
Safety advice
Use of Minerva 50mg Tablet is not recommended in patients with severe kidney disease.
What if you forget to take Minerva Tablet?
All substitutes
Quick tips
- Minerva 50mg Tablet lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.
- Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.
- Minerva 50mg Tablet is used together with other diabetes medicines to control blood sugar and avoid long-term complications.
- Minerva 50mg Tablet lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.
- Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Minerva 50mg Tablet.
Fact Box
Interaction with drugs
User feedback
FAQs
Is Minerva 50mg Tablet safe?
How does Minerva 50mg Tablet work?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Powers AC, D’Alessio D. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1264.
- Nolte MS. Pancreatic hormones and antidiabetic drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 743-44.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 919-920.






